Published in Antimicrob Agents Chemother on July 01, 1977
The antimicrobial susceptibility of Chlamydia trachomatis in cell culture. Br J Vener Dis (1978) 3.74
Relative resistance to erythromycin in Chlamydia trachomatis. Antimicrob Agents Chemother (1980) 2.55
In vitro drug susceptibility of Chlamydia sp. strain TWAR. Antimicrob Agents Chemother (1988) 1.99
In vitro assays of the efficacy of antimicrobial agents in controlling Chlamydia trachomatis propagation. Antimicrob Agents Chemother (1978) 1.74
Comparison of the in vitro activities of ofloxacin and tetracycline against Chlamydia trachomatis as assessed by indirect immunofluorescence. Antimicrob Agents Chemother (1984) 1.72
In vitro susceptibility of 30 strains of Chlamydia trachomatis to rosamicin. Antimicrob Agents Chemother (1978) 1.59
In vitro activity of A-56268 (TE-031) and four other antimicrobial agents against Chlamydia trachomatis. Antimicrob Agents Chemother (1987) 1.34
Susceptibility testing of Chlamydia trachomatis: from eggs to monoclonal antibodies. Antimicrob Agents Chemother (1988) 1.23
Antimicrobial activity of U-70138F (paldimycin), roxithromycin (RU 965), and ofloxacin (ORF 18489) against Chlamydia trachomatis in cell culture. Antimicrob Agents Chemother (1986) 1.23
Standardized method for determining antimicrobial susceptibility of strains of Ureaplasma urealyticum and their response to tetracycline, erythromycin, and rosaramicin. Antimicrob Agents Chemother (1981) 1.19
Immediate cytotoxicity of Chlamydia trachomatis for mouse peritoneal macrophages. Infect Immun (1978) 1.15
In vitro activity of A-56268 (TE-031), a new macrolide, compared with that of erythromycin and clindamycin against selected gram-positive and gram-negative organisms. Antimicrob Agents Chemother (1987) 1.06
In vitro activity of clavulanic acid, amoxicillin, and ticarcillin against Chlamydia trachomatis. Antimicrob Agents Chemother (1986) 0.99
Chlamydia trachomatis in gonococcal and postgonococcal urethritis. Br J Vener Dis (1978) 0.96
Chlamydia infection depends on a functional MDM2-p53 axis. Nat Commun (2014) 0.94
Susceptibilities of Chlamydia trachomatis isolates causing uncomplicated female genital tract infections and pelvic inflammatory disease. Antimicrob Agents Chemother (1995) 0.93
Effects of chloramphenicol on Chlamydia trachomatis infection in neonatal conjunctivitis and in McCoy cell cultures. J Hyg (Lond) (1982) 0.91
In Vitro Susceptibility Testing of Clinical Isolates of Chlamydia trachomatis. Infect Dis Obstet Gynecol (1993) 0.86
Treatment of nongonococcal urethritis with trimethoprim-sulphadiazine and with placebo. A double-blind partner-controlled study. Br J Vener Dis (1980) 0.86
Penicillin kills Chlamydia following the fusion of bacteria with lysosomes and prevents genital inflammatory lesions in C. muridarum-infected mice. PLoS One (2013) 0.80
N-acylated derivatives of sulfamethoxazole and sulfafurazole inhibit intracellular growth of Chlamydia trachomatis. Antimicrob Agents Chemother (2014) 0.78
In vitro and in vivo efficacy of antimicrobials against Chlamydia trachomatis. Infection (1982) 0.77
Pharmacokinetics of erythromycin ethylsuccinate and estolate in infants under 4 months of age. Antimicrob Agents Chemother (1981) 0.76
In vitro activity of rosaramicin against Chlamydia trachomatis. Antimicrob Agents Chemother (1980) 0.75
Chlamydia (uncomplicated, genital). BMJ Clin Evid (2010) 0.75
Chlamydia (uncomplicated, genital). BMJ Clin Evid (2008) 0.75
Chlamydia (uncomplicated, genital). BMJ Clin Evid (2015) 0.75
Cefotaxime treatment of pelvic inflammatory disease. Antimicrob Agents Chemother (1981) 0.75
ISOLATION OF THE TRACHOMA AGENT IN CELL CULTURE. Proc Soc Exp Biol Med (1965) 7.38
Primary isolation of TRIC organisms in HeLa 229 cells treated with DEAE-dextran. J Infect Dis (1972) 6.85
Further classification of TRIC agents from ocular trachoma and other sources by the mouse toxicity prevention test. Am J Ophthalmol (1967) 3.63
A new Micromonospora-produced macrolide antibiotic, rosamicin. J Antibiot (Tokyo) (1972) 3.12
Biological studies with rosamicin, a new Micromonospora-produced macrolide antibiotic. J Antibiot (Tokyo) (1972) 3.08
Three new immunologic types of trachoma-inclusion conjunctivitis organisms. J Immunol (1973) 2.96
TRIC type K, a new immunologic type of Chlamydia trachomatis. J Immunol (1974) 2.22
Chlamydia trachomatis immunotype J. J Immunol (1975) 1.73
Chemotherapy of chlamydial infections. Adv Pharmacol Chemother (1969) 1.68
Sensitivity and resistance of TRIC agents to penicillin, tetracycline and sulfa drugs. Am J Ophthalmol (1967) 1.17
Susceptibility of a trachoma agent grown in FL cell cultures to antibiotics and a sulfa drug. Proc Soc Exp Biol Med (1962) 1.17
Production and properties of a penicillinresistant strain of feline pneumonitis virus. J Infect Dis (1955) 1.08
Experimental chemotherapy of infection with agents of the psittacosis-lymphogranuloma-trachoma group. Ann N Y Acad Sci (1962) 1.03
Development of resistance to penicillin and to chlortetracycline in psittacosis virus. Virology (1957) 1.01
Sensitivity of mouse pneumonitis organisms to ampicillin. Br Med J (1962) 0.95
Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organisms in a new microtiter indirect immunofluorescence test. Am J Ophthalmol (1970) 10.68
Etiology of nongonococcal urethritis. N Engl J Med (1975) 9.61
New knowledge of chlamydiae and the diseases they cause. J Infect Dis (1975) 9.35
Monoclonal antibodies to Chlamydia trachomatis: antibody specificities and antigen characterization. J Immunol (1982) 8.61
A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med (1986) 8.03
Primary isolation of TRIC organisms in HeLa 229 cells treated with DEAE-dextran. J Infect Dis (1972) 6.85
A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis (1990) 6.52
Human serology in Chlamydia trachomatis infection with microimmunofluorescence. J Infect Dis (1974) 6.18
Culture-independent diagnosis of Chlamydia trachomatis using monoclonal antibodies. N Engl J Med (1984) 6.08
Immunotyping of Chlamydia trachomatis with monoclonal antibodies. J Infect Dis (1985) 5.29
Polymicrobial etiology of acute pelvic inflammatory disease. N Engl J Med (1975) 4.99
Chlamydia pneumoniae (TWAR). Clin Microbiol Rev (1995) 4.93
Mucopurulent cervicitis--the ignored counterpart in women of urethritis in men. N Engl J Med (1984) 4.74
New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine (Baltimore) (1990) 4.04
Neisseria gonorrhoeae acquire a new principal outer-membrane protein when transformed to resistance to serum bactericidal activity. Infect Immun (1978) 4.03
Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis (1993) 4.02
Sensitivity of immunofluorescence with monoclonal antibodies for detection of Chlamydia trachomatis inclusions in cell culture. J Clin Microbiol (1982) 3.64
Further classification of TRIC agents from ocular trachoma and other sources by the mouse toxicity prevention test. Am J Ophthalmol (1967) 3.63
Further Studies in Adult Rickets (Osteomalacia) and Foetal Rickets: (Section of Obstetrics and Gynaecology). Proc R Soc Med (1939) 3.56
Importance of reinfection in the pathogenesis of trachoma. Rev Infect Dis (1986) 3.50
Interaction of Chlamydia trachomatis organisms and HeLa 229 cells. Infect Immun (1976) 3.44
Antigenic analysis of Chlamydiae by two-dimensional immunoelectrophoresis. I. Antigenic heterogeneity between C. trachomatis and C. psittaci. J Immunol (1975) 3.41
Chlamydia trachomatis as possible cause of peritonitis and perihepatitis in young women. Br Med J (1978) 3.33
Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix. Infect Immun (1983) 3.22
Etiology of nongonococcal urethritis. Evidence for Chlamydia trachomatis and Ureaplasma urealyticum. J Clin Invest (1977) 3.18
Current knowledge on Chlamydia pneumoniae, strain TWAR, an important cause of pneumonia and other acute respiratory diseases. Eur J Clin Microbiol Infect Dis (1989) 3.15
Identification of a new group of Chlamydia psittaci strains called TWAR. J Clin Microbiol (1986) 3.11
Simplified microimmunofluorescence test with trachoma-lymphogranuloma venereum (Chlamydia trachomatis) antigens for use as a screening test for antibody. J Clin Microbiol (1975) 3.03
Chlamydia trachomatis proctitis. N Engl J Med (1981) 3.02
Pneumonia associated with the TWAR strain of Chlamydia. Ann Intern Med (1987) 3.00
Three new immunologic types of trachoma-inclusion conjunctivitis organisms. J Immunol (1973) 2.96
A simplified method for immunological typing of trachoma-inclusion conjunctivitis-lymphogranuloma venereum organisms. Infect Immun (1973) 2.93
Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis (1995) 2.90
Characterization of the new Chlamydia agent, TWAR, as a unique organism by restriction endonuclease analysis and DNA-DNA hybridization. J Clin Microbiol (1987) 2.78
Immunotypes of Chlamydia trachomatis isolates in Seattle, Washington. Infect Immun (1983) 2.76
Alcohol and aldehyde dehydrogenase genotypes and alcoholism in Chinese men. Am J Hum Genet (1991) 2.75
A sensitive cell line, HL cells, for isolation and propagation of Chlamydia pneumoniae strain TWAR. J Infect Dis (1990) 2.74
Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2. J Virol (2000) 2.71
Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis (2001) 2.71
Trachoma vaccine studies in monkeys. Am J Ophthalmol (1967) 2.65
Infections with Campylobacter jejuni and Campylobacter-like organisms in homosexual men. Ann Intern Med (1984) 2.65
Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. JAMA (1992) 2.61
Unique ultrastructure in the elementary body of Chlamydia sp. strain TWAR. J Bacteriol (1987) 2.61
An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci. J Infect Dis (1985) 2.60
Mycoplasma pneumoniae pneumonia in an urban area. Five years of surveillance. JAMA (1970) 2.58
Epidemiology of Mycoplasma pneumoniae infection in families. JAMA (1966) 2.49
Detection of Chlamydia pneumoniae by polymerase chain reaction. J Clin Microbiol (1992) 2.49
Comparative susceptibility of eleven mammalian cell lines to infection with trachoma organisms. J Clin Microbiol (1975) 2.48
Factors affecting viability and growth in HeLa 229 cells of Chlamydia sp. strain TWAR. J Clin Microbiol (1988) 2.41
Antigen-specific human antibodies from mice comprising four distinct genetic modifications. Nature (1994) 2.39
Increased frequency of serum antibodies to Chlamydia trachomatis in infertility due to distal tubal disease. Lancet (1982) 2.38
Immunochemical studies on chlamydial group antigen (presence of a 2-keto-3-deoxycarbohydrate as immunodominant group). J Immunol (1972) 2.37
Differentiation of TRIC and LGV organisms based on enhancement of infectivity by DEAE-dextran in cell culture. J Infect Dis (1972) 2.36
Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J (1992) 2.28
Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler Thromb (1993) 2.27
Three new serovars of Chlamydia trachomatis: Da, Ia, and L2a. J Infect Dis (1991) 2.26
Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation (1995) 2.24
Sustained atrial tachycardia in adult patients. Electrophysiological characteristics, pharmacological response, possible mechanisms, and effects of radiofrequency ablation. Circulation (1994) 2.24
Molecular cloning and expression of Chlamydia trachomatis major outer membrane protein antigens in Escherichia coli. Infect Immun (1985) 2.24
TRIC type K, a new immunologic type of Chlamydia trachomatis. J Immunol (1974) 2.22
Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci U S A (1995) 2.15
Epidemics of pneumonia caused by TWAR, a new Chlamydia organism, in military trainees in Finland. J Infect Dis (1988) 2.15